Skip to main content

Table 1 Number and incidence rate of bladder, kidney and prostate cancer by sex and age at 1990, 2019 and projected 2030

From: Secular trends of morbidity and mortality of prostate, bladder, and kidney cancers in China, 1990 to 2019 and their predictions to 2030

 

Number of cases (95% UI) (per 1000)

Incidence rate (95% UI) (× 100,000)

EAPC (95% CI)

1990

2019

2030

1990

2019

2030

1990 ~ 2019

2020 ~ 2030

Prostate

Male a

26·44(19·45,33·23)

153·45(115·66,209·60)

315·31(223·82,406·79)

8·69(6·53,11·15)

18·72(14·18,25·27)

25·54(18·11,32·97)

3·00(2·86,3·15)

2·88(2·84,2·93)

Age group

        

0 ~ 19 b

-

-

-

-

-

-

-

-

20 ~ 39 b

0·35(0·24,0·44)

1·07(0·83,1·46)

1·15(0·63,1·68)

0·17(0·11,0·21)

0·49(0·38,0·67)

0·62(0·34,0·91)

3·92(3·76,4·09)

2·44(2·10,2·78)

40 ~ 59 b

3·06(2·04,3·96)

16·41(11·75,23·47)

23·97(16·98,30·96)

2·92(1·95,3·77)

7·39(5·30,10·58)

10·76(7·62,13·90)

3·58(3·34,3·81)

2·77(2·12,3·41)

60 ~ 79 b

18·58(13·63,22·89)

106·44(80·11,146·99)

225·10(159·97,290·22)

40·57(29·77,50·00)

100·44(75·59,138·70)

143·66(102·10,185·22)

3·41(3·23,3·60)

3·30(3·19,3·41)

80 ~ b

4·45(3·54,5·94)

29·53(22·97,37·69)

65·09(46·25,83·94)

165·54(131·57,220·90)

289·91(225·55,370·07)

398·53(283·16,513·91)

2·46(2·14,2·79)

3·24(3·02,3·46)

Bladder

Total a

25·55(21·85,29·58)

100·02(81·83,120·39)

192·39(118·60,266·17)

3·38(2·89,3·90)

5·59(4·60,6·69)

7·54(4·64,10·44)

2·04(1·91,2·17)

2·58(2·54,2·61)

Male a

18·36(21·85,29·58)

82·68(81·83,120·39)

160·04(99·09,220·99)

5·38(6·62,8·92)

9·92(10·05,14·53)

13·46(8·32,18·60)

2·46(2·31,2·60)

2·66(2·62,2·69)

Female a

7·19(21·85,29·58)

17·34(81·83,120·39)

30·36(17·09,43·63)

1·82(5·36,7·24)

1·87(8·66,12·64)

2·28(1·27,3·29)

0·16(0·05,0·27)

1·80(1·77,1·83)

Age group

        

0 ~ 19 b

0·22(0·18,0·27)

0·17(0·14,0·21)

0·23(0·02,0·44)

0·18(0·15,0·21)

0·21(0·17,0·26)

0·27(0·03,0·51)

0·24(0·03,0·44)

2·80(2·63,2·96)

20 ~ 39 b

2·25(1·91,2·65)

4·58(3·77,5·48)

4·02(2·40,5·65)

0·54(0·46,0·64)

1·10(0·91,1·31)

1·16(0·69,1·63)

2·24(2·08,2·40)

1·48(0·90,2·07)

40 ~ 59 b

6·20(5·22,7·25)

22·36(17·57,27·74)

30·50(18·82,42·18)

3·09(2·60,3·61)

5·12(4·02,6·35)

7·00(4·32,9·68)

2·14(1·92,2·36)

2·15(1·78,2·53)

60 ~ 79 b

13·58(11·71,15·65)

55·17(45·18,66·59)

119·79(74·00,165·57)

14·69(12·66,16·93)

25·48(20·87,30·75)

37·17(22·96,51·37)

2·15(1·94,2·37)

3·10(2·98,3·22)

80 ~ b

3·29(2·83,3·76)

17·74(15·16,20·37)

37·85(23·37,52·33)

43·94(37·71,50·22)

69·23(59·17,79·52)

91·75(56·64,126·86)

2·03(1·71,2·35)

2·78(2·65,2·91)

Kidney

Total a

11·07(9·30,13·08)

59·83(48·82,72·66)

126·98(12·62,241·71)

1·16(0·98,1·36)

3·34(2·73,4·04)

5·63(0·53,10·79)

4·59(4·10,5·07)

4·78(4·54,5·02)

Male a

6·16(4·76,7·79)

42·55(32·52,54·27)

102·91(0·00,218·36)

1·32(1·03,1·66)

4·79(3·69,6·07)

9·09(0·00,19·34)

5·59(5·04,6·15)

5·77(5·45,6·10)

Female a

4·92(3·94,6·03)

17·27(13·44,21·87)

30·96(9·53,52·42)

1·02(0·82,1·24)

1·98(1·54,2·51)

2·91(0·80,5·02)

2·88(2·50,3·26)

3·56(3·39,3·72)

Age group

        

0 ~ 19 b

2·58(2·12,3·07)

2·51(2·06,3·03)

2·60(0·06,5·50)

0·56(0·46,0·66)

0·74(0·61,0·89)

0·90(0·02,1·90)

1·52(1·18,1·86)

1·96(1·43,2·49)

20 ~ 39 b

1·42(1·18,1·69)

6·30(5·19,7·58)

7·02(0·70,13·35)

0·34(0·28,0·41)

1·51(1·25,1·82)

2·02(0·20,3·84)

6·40(5·72,7·08)

2·88(2·25,3·51)

40 ~ 59 b

3·18(2·66,3·83)

22·44(17·81,28·04)

44·60(4·49,84·72)

1·59(1·33,1·91)

5·14(4·08,6·42)

10·23(1·03,19·43)

5·29(4·71,5·88)

5·52(5·41,5·63)

60 ~ 79 b

3·45(2·97,3·99)

23·77(19·72,28·42)

61·40(6·19,116·61)

3·73(3·21,4·31)

10·98(9·11,13·12)

19·05(1·92,36·18)

4·50(3·97,5·03)

5·39(5·17,5·61)

80 ~ b

0·45(0·38,0·51)

4·80(4·04,5·59)

11·37(1·14,21·60)

5·97(5·11,6·79)

18·75(15·76,21·83)

27·56(2·76,52·37)

5·48(4·84,6·12)

3·59(3·18,4·01)

  1. EAPC estimated annual percentage change, 95% UI 95% uncertainty interval, 95% CI 95% confidence interval
  2. a age-standardized incidence rate
  3. b crude incidence rate in each age group